Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach.

about

Corrigendum: Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach.

P921

Q52640951-FC601F4B-A382-4AE9-BC48-E057D7251F5F

P921

Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach.

Item

http://www.wikidata.org/entity/Q52674779

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach.

@en

Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach.

@nl

type

Item

label

Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach.

@en

Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach.

@nl

prefLabel

Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach.

@en

Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach.

@nl

P1476

Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach.

@en

P2093

Keitaro Fukuda

http://www.w3.org/2001/XMLSchema#string

P2507

Corrigendum: Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach.

P2860

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.

Metastatic Extramammary Paget's Disease of Scrotum Responds Completely to Single Agent Trastuzumab in a Hemodialysis Patient: Case Report, Molecular Profiling and Brief Review of the Literature.

HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

TGF-beta-induced epithelial to mesenchymal transition

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.

A Case of Metastatic Extramammary Paget's Disease Responding to Trastuzumab plus Paclitaxel Combination Therapy.

Potential use of bisphosphonates in invasive extramammary Paget's disease: an immunohistochemical Investigation.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2018.00038

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Takeru Funakoshi

P577

2018-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29503810

http://www.w3.org/2001/XMLSchema#string

P932

5820294

http://www.w3.org/2001/XMLSchema#string

Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach.

about

P921

P921

Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2507

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2507

P2860

P304

P31

P356

P478

P50

P577

P698

P932